Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neoplasms 2Inflammation 2Uveal Melanoma 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Eye Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cachexia 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Ipilimumab 3Triamcinolone Acetonide 2Ranibizumab 2Nivolumab 2Amplified Fragment Length Polymorphism Analysis 2treosulfan 1salicylhydroxamic acid 1aldesleukin 1Ultrasonography 1Tramadol 1Temozolomide 1Tamoxifen 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Sorafenib 1Rose Bengal 1Radiosurgery 1Physical Examination 1Pharmacogenomic Testing 1Interviews as Topic 1Immunotherapy 1Ibuprofen 1Gemcitabine 1Eye Enucleation 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1CTLA-4 Antigen 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Uveal Melanoma × Ibuprofen × Clear all
NCT00111046 2005-11-10

Pain Relief - Tramadol Versus Ibuprofen

Royal Liverpool University Hospital

Phase 1/2 Unknown
40 enrolled
Dermatologic

Uveal Melanoma, Eye Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡